Royal Bank of Canada’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.59M Buy
479,782
+466,302
+3,459% +$5.43M ﹤0.01% 2258
2025
Q1
$100K Sell
13,480
-1,375
-9% -$10.2K ﹤0.01% 4863
2024
Q4
$88K Buy
14,855
+3,139
+27% +$18.6K ﹤0.01% 4942
2024
Q3
$60K Buy
11,716
+472
+4% +$2.42K ﹤0.01% 5148
2024
Q2
$40K Buy
11,244
+7,402
+193% +$26.3K ﹤0.01% 5360
2024
Q1
$12K Sell
3,842
-30,643
-89% -$95.7K ﹤0.01% 5673
2023
Q4
$169K Buy
34,485
+32,115
+1,355% +$157K ﹤0.01% 4721
2023
Q3
$13K Sell
2,370
-12,319
-84% -$67.6K ﹤0.01% 5832
2023
Q2
$98K Buy
14,689
+5,646
+62% +$37.7K ﹤0.01% 4918
2023
Q1
$80K Sell
9,043
-12,345
-58% -$109K ﹤0.01% 4965
2022
Q4
$163K Buy
21,388
+16,021
+299% +$122K ﹤0.01% 4592
2022
Q3
$38K Buy
5,367
+250
+5% +$1.77K ﹤0.01% 5382
2022
Q2
$41K Sell
5,117
-2,900
-36% -$23.2K ﹤0.01% 5340
2022
Q1
$111K Buy
8,017
+2,885
+56% +$39.9K ﹤0.01% 5097
2021
Q4
$144K Sell
5,132
-730
-12% -$20.5K ﹤0.01% 5135
2021
Q3
$199K Sell
5,862
-350
-6% -$11.9K ﹤0.01% 4675
2021
Q2
$254K Sell
6,212
-8,946
-59% -$366K ﹤0.01% 4400
2021
Q1
$611K Buy
15,158
+13,731
+962% +$553K ﹤0.01% 3572
2020
Q4
$84K Buy
1,427
+613
+75% +$36.1K ﹤0.01% 4889
2020
Q3
$40K Sell
814
-60,189
-99% -$2.96M ﹤0.01% 4949
2020
Q2
$2.95M Sell
61,003
-1,679
-3% -$81.2K ﹤0.01% 2036
2020
Q1
$1.74M Buy
62,682
+59,889
+2,144% +$1.66M ﹤0.01% 2248
2019
Q4
$84K Sell
2,793
-8,386
-75% -$252K ﹤0.01% 4593
2019
Q3
$344K Buy
11,179
+5,124
+85% +$158K ﹤0.01% 3536
2019
Q2
$293K Buy
+6,055
New +$293K ﹤0.01% 3681